<code id='4BF47A1BE3'></code><style id='4BF47A1BE3'></style>
    • <acronym id='4BF47A1BE3'></acronym>
      <center id='4BF47A1BE3'><center id='4BF47A1BE3'><tfoot id='4BF47A1BE3'></tfoot></center><abbr id='4BF47A1BE3'><dir id='4BF47A1BE3'><tfoot id='4BF47A1BE3'></tfoot><noframes id='4BF47A1BE3'>

    • <optgroup id='4BF47A1BE3'><strike id='4BF47A1BE3'><sup id='4BF47A1BE3'></sup></strike><code id='4BF47A1BE3'></code></optgroup>
        1. <b id='4BF47A1BE3'><label id='4BF47A1BE3'><select id='4BF47A1BE3'><dt id='4BF47A1BE3'><span id='4BF47A1BE3'></span></dt></select></label></b><u id='4BF47A1BE3'></u>
          <i id='4BF47A1BE3'><strike id='4BF47A1BE3'><tt id='4BF47A1BE3'><pre id='4BF47A1BE3'></pre></tt></strike></i>

          Home / hotspot / leisure time

          leisure time


          leisure time

          author:hotspot    Page View:7257
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In